Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Sell
35
ATUS Quote, Financials, Valuation and Earnings
Last price:
$2.49
Seasonality move
:
-5.33%
Day range:
$2.48 - $2.64
52-week range:
$1.52 - $3.66
Dividend yield:
0%
P/E ratio:
197.00x
P/S ratio:
0.13x
P/B ratio:
--
Volume:
2.5M
Avg. volume:
3.6M
1-year change:
-7.75%
Market cap:
$1.2B
Revenue:
$9.2B
EPS (TTM):
-$0.37
Analysts' Opinion
-
Consensus RatingAltice USA has received a consensus rating of . The company's average rating is a based on 5 Buy ratings, 9 Hold ratings, and 2 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of $3.80, Altice USA has an estimated downside of -7.47% from its current price of $2.50.
-
Price Target UpsideAccording to analysts, the highest upside price target is $11.00 representing -100% upside increase from its current price of $2.50.
Fair Value
-
According to the consensus of 0 analysts, Altice USA has -7.47% downside to fair value with a price target of $3.80 per share.
ATUS vs. S&P 500
-
Over the past 5 trading days, Altice USA has underperformed the S&P 500 by -6.21% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Altice USA does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Altice USA revenues have been falling on a year-over-year basis for 12 quarters in a row. In the most recent quarter Altice USA reported revenues of $2.2B.
Earnings Growth
-
Altice USA earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Altice USA reported earnings per share of -$0.09.
Enterprise value:
25.8B
EV / Invested capital:
1.05x
Price / LTM sales:
0.13x
EV / EBIT:
16.33x
EV / Revenue:
2.86x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
85.87x
Price / Operating cash flow:
3.81x
Enterprise value / EBITDA:
8.17x
Gross Profit (TTM):
$6.1B
Return On Assets:
-0.52%
Net Income Margin (TTM):
-1.85%
Return On Equity:
--
Return On Invested Capital:
-0.68%
Operating Margin:
20.45%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $9.8B | $9.3B | $9B | $2.3B | $2.2B | |
| Gross Profit | $6.5B | $6.2B | $6.1B | $1.6B | $1.5B | |
| Operating Income | $2.1B | $1.9B | $1.8B | $497M | $455.5M | |
| EBITDA | $3.9B | $3.5B | $3.2B | $925.4M | $783.8M | |
| Diluted EPS | $1.41 | -$0.05 | -$0.37 | $0.15 | -$0.09 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $1.6B | $844.7M | $2.5B | $801.1M | $865.3M | |
| Total Assets | $33.9B | $33.4B | $33.3B | $32.2B | $31.8B | |
| Current Liabilities | $2B | $3.7B | $4B | $3.1B | $2.1B | |
| Total Liabilities | $33.2B | $34.6B | $33.6B | $32.5B | $32.3B | |
| Total Equity | $745.3M | -$1.1B | -$339.1M | -$321.3M | -$422.6M | |
| Total Debt | $25.5B | $26.6B | $26.1B | $24.9B | $24.9B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.6B | $1.8B | $1.6B | $474.5M | $436M | |
| Cash From Investing | -$1.8B | -$2B | -$1.3B | -$353.3M | -$360.1M | |
| Cash From Financing | -$801.8M | $184.3M | -$316.2M | -$69.9M | -$188.5M | |
| Free Cash Flow | $824.6M | -$161.4M | $300.5M | $121.3M | $76.9M | |
ATUS
Sector
Market Cap
$1.2B
$112.9M
Price % of 52-Week High
68.31%
65.22%
Dividend Yield
0%
0%
Shareholder Yield
--
3.48%
1-Year Price Total Return
-7.75%
-17.6%
Beta (5-Year)
1.528
0.704
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$2.58
200-day SMA
Buy
Level
$2.24
Bollinger Bands (100)
Buy
Level
1.93 - 2.61
Chaikin Money Flow
Sell
Level
-167.3M
20-day SMA
Sell
Level
$2.54
Relative Strength Index (RSI14)
Sell
Level
48.26
ADX Line
Buy
Level
8.23
Williams %R
Neutral
Level
-51.1628
50-day SMA
Sell
Level
$2.52
MACD (12, 26)
Buy
Level
0.02
25-day Aroon Oscillator
Buy
Level
16
On Balance Volume
Neutral
Level
4M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.4168)
Sell
CA Score
(Annual)
Level (-2.4719)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (3.9168)
Buy
Piotroski F Score
(Annual)
Level (6)
Sell
Quality Ratio Score
Level (3)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Altice Europe acquired privately held us cable company Suddenlink in 2015 and Cablevision in 2016. Suddenlink’s networks provide television, internet access, and phone services to roughly 4 million us homes and businesses located primarily in smaller markets, with major clusters in Texas, West Virginia, Idaho, Arizona, and Louisiana. Cablevision provides comparable services to about 5.5 million homes and business in the New York City metro area. Both regions now operate under the Optimum brand name. Altice Europe spun off Altice USA, which includes both the Suddenlink and Cablevision operations, to shareholders in 2018. Altice USA also owns News 12 Networks, which broadcasts local news in New York and i24News, a news operation focused on the Middle East.
Stock Forecast FAQ
In the current month, ATUS has received 5 Buy ratings 9 Hold ratings, and 2 Sell ratings. The ATUS average analyst price target in the past 3 months is $3.80.
-
Where Will Altice USA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Altice USA share price will drop to $3.80 per share over the next 12 months.
-
What Do Analysts Say About Altice USA?
Analysts are divided on their view about Altice USA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Altice USA is a Sell and believe this share price will rise from its current level to $1.00.
-
What Is Altice USA's Price Target?
The price target for Altice USA over the next 1-year time period is forecast to be $3.80 according to 0 Wall Street analysts, 5 of them rate the stock a Buy, 2 rate the stock a Sell, and 9 analysts rate the stock a Hold.
-
Is ATUS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Altice USA is a . 0 of 0 analysts rate the stock a at this time.
-
How Can I Buy Shares Of ATUS?
You can purchase shares of Altice USA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Altice USA shares.
-
What Is The Altice USA Share Price Today?
Altice USA was last trading at $2.49 per share. This represents the most recent stock quote for Altice USA. Yesterday, Altice USA closed at $2.50 per share.
-
How To Buy Altice USA Stock Online?
In order to purchase Altice USA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 8.51% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 0.76% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is down 0.86% over the past day.
